Molecular mechanisms of migraine: Nitric oxide synthase and neuropeptides

N Karsan, H Gosalia, PJ Goadsby - International Journal of Molecular …, 2023 - mdpi.com
Migraine is a common condition with disabling attacks that burdens people in the prime of
their working lives. Despite years of research into migraine pathophysiology and …

Calcitonin gene-related peptide (CGRP)-targeted monoclonal antibodies and antagonists in migraine: current evidence and rationale

F Cohen, H Yuan, SD Silberstein - BioDrugs, 2022 - Springer
Calcitonin gene-related peptide (CGRP), a 37 amino-acid neuropeptide found mostly in
peptidergic sensory C-fibers, has been suggested to be implicated in the pathogenesis of …

The American Headache Society Consensus Statement: Update on integrating new migraine treatments into clinical practice

J Ailani, RC Burch, MS Robbins… - … : The Journal of …, 2021 - Wiley Online Library
Objective To incorporate recent research findings, expert consensus, and patient
perspectives into updated guidance on the use of new acute and preventive treatments for …

New oral drugs for migraine

N Karsan, PJ Goadsby - CNS drugs, 2022 - Springer
Migraine is a common and disabling neurological disorder, with several manifestations, of
which pain is just one. Despite its worldwide prevalence, there remains a paucity of targeted …

Calcitonin gene-related peptide (CGRP)-targeted therapies as preventive and acute treatments for migraine—the monoclonal antibodies and gepants

CC Chiang, TJ Schwedt - Progress in brain research, 2020 - Elsevier
Abstract Calcitonin Gene-Related Peptide (CGRP) plays a pivotal role in migraine
pathophysiology. Two types of CGRP function-blocking modalities, monoclonal antibodies …

Real-world effectiveness, satisfaction, and optimization of ubrogepant for the acute treatment of migraine in combination with onabotulinumtoxinA: results from the …

A Manack Adams, S Hutchinson, E Engstrom… - The Journal of …, 2023 - Springer
Background Individuals using onabotulinumtoxinA as a preventive migraine treatment often
use acute treatments for breakthrough attacks. Data on real-world effectiveness of the small …

Photophobia: shared pathophysiology underlying dry eye disease, migraine and traumatic brain injury leading to central neuroplasticity of the trigeminothalamic …

RJ Diel, D Mehra, R Kardon, DC Buse… - British Journal of …, 2021 - bjo.bmj.com
Background Photophobia is a potentially debilitating symptom often found in dry eye
disease (DE), migraine and traumatic brain injury (TBI). Methods We conducted a review of …

A novel, injury-free rodent model of vulnerability for assessment of acute and preventive therapies reveals temporal contributions of CGRP-receptor activation in …

CM Kopruszinski, E Navratilova, J Swiokla… - …, 2021 - journals.sagepub.com
Aim Development and characterization of a novel injury-free preclinical model of migraine-
like pain allowing mechanistic assessment of both acute and preventive treatments …

Targeting adrenomedullin in oncology: A feasible strategy with potential as much more than an alternative anti-angiogenic therapy

R Vázquez, ME Riveiro, C Berenguer-Daize… - Frontiers in …, 2021 - frontiersin.org
The development, maintenance and metastasis of solid tumors are highly dependent on the
formation of blood and lymphatic vessels from pre-existing ones through a series of …

New approaches to shifting the migraine treatment paradigm

B Johnson, FG Freitag - Frontiers in Pain Research, 2022 - frontiersin.org
The standard of care paradigm for migraine treatment has been based almost exclusively on
approaches that grew out of the happenstance use of market pharmaceuticals. Only …